<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Genet</journal-id><journal-id journal-id-type="iso-abbrev">Front Genet</journal-id><journal-id journal-id-type="publisher-id">Front. Genet.</journal-id><journal-title-group><journal-title>Frontiers in Genetics</journal-title></journal-title-group><issn pub-type="epub">1664-8021</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7721480</article-id><article-id pub-id-type="doi">10.3389/fgene.2020.566159</article-id><article-categories><subj-group subj-group-type="heading"><subject>Genetics</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Identifying 8-mRNAsi Based Signature for Predicting Survival in Patients With Head and Neck Squamous Cell Carcinoma via Machine Learning</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tian</surname><given-names>Yuxi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/1108678/overview"/></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Juncheng</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Qin</surname><given-names>Chao</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zhu</surname><given-names>Gangcai</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/787770/overview"/></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Xuan</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Zhixiang</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Qin</surname><given-names>Yuexiang</given-names></name><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wei</surname><given-names>Ming</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/965733/overview"/></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Zhexuan</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Xin</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="c002"><sup>*</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lv</surname><given-names>Yunxia</given-names></name><xref ref-type="aff" rid="aff8"><sup>8</sup></xref><xref ref-type="corresp" rid="c003"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/781137/overview"/></contrib><contrib contrib-type="author"><name><surname>Cai</surname><given-names>Gengming</given-names></name><xref ref-type="aff" rid="aff9"><sup>9</sup></xref><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/787626/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Oncology, Xiangya Hospital, Central South University</institution>, <addr-line>Changsha</addr-line>, <country>China</country></aff><aff id="aff2"><sup>2</sup><institution>Department of Otolaryngology Head and Neck Surgery, Xiangya Hospital, Central South University</institution>, <addr-line>Changsha</addr-line>, <country>China</country></aff><aff id="aff3"><sup>3</sup><institution>Department of Neurosurgery, The First People&#x02019;s Hospital of Changde City</institution>, <addr-line>Changde</addr-line>, <country>China</country></aff><aff id="aff4"><sup>4</sup><institution>Department of Otolaryngology Head and Neck Surgery, The Second Xiangya Hospital, Central South University</institution>, <addr-line>Changsha</addr-line>, <country>China</country></aff><aff id="aff5"><sup>5</sup><institution>Department of Stomatology, Changzheng Hospital, Second Military Medical University</institution>, <addr-line>Shanghai</addr-line>, <country>China</country></aff><aff id="aff6"><sup>6</sup><institution>Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University</institution>, <addr-line>Haikou</addr-line>, <country>China</country></aff><aff id="aff7"><sup>7</sup><institution>Department of Health Management, The Third Xiangya Hospital, Central South University</institution>, <addr-line>Changsha</addr-line>, <country>China</country></aff><aff id="aff8"><sup>8</sup><institution>Department of Thyroid Surgery, The Second Affiliated Hospital of Nanchang University</institution>, <addr-line>Nanchang</addr-line>, <country>China</country></aff><aff id="aff9"><sup>9</sup><institution>Department of Otolaryngology Head and Neck Surgery, First Affiliated Hospital of Quanzhou, Fujian Medical University</institution>, <addr-line>Quanzhou</addr-line>, <country>China</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Deema Hussein, King Abdulaziz University, Saudi Arabia</p></fn><fn fn-type="edited-by"><p>Reviewed by: Caroline Moyret-Lalle, INSERM U1052 Centre de Recherche en Cancerologie de Lyon, France; Wei Cao, Shanghai Jiao Tong University, China</p></fn><corresp id="c001">*Correspondence: Gengming Cai, <email>cgmkgx@hotmail.com</email></corresp><corresp id="c002">Xin Zhang, <email>xinzhang@csu.edu.cn</email></corresp><corresp id="c003">Yunxia Lv, <email>83394045@qq.com</email></corresp><fn fn-type="other" id="fn002"><p><sup>&#x02020;</sup>These authors have contributed equally to this work</p></fn><fn fn-type="other" id="fn004"><p>This article was submitted to Cancer Genetics, a section of the journal Frontiers in Genetics</p></fn></author-notes><pub-date pub-type="epub"><day>29</day><month>10</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>11</volume><elocation-id>566159</elocation-id><history><date date-type="received"><day>27</day><month>5</month><year>2020</year></date><date date-type="accepted"><day>29</day><month>9</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 Tian, Wang, Qin, Zhu, Chen, Chen, Qin, Wei, Li, Zhang, Lv and Cai.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Tian, Wang, Qin, Zhu, Chen, Chen, Qin, Wei, Li, Zhang, Lv and Cai</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Cancer stem cells (CSCs) have been characterized by several exclusive features that include differentiation, self-renew, and homeostatic control, which allows tumor maintenance and spread. Recurrence and therapeutic resistance of head and neck squamous cell carcinomas (HNSCC) have been identified to be attributed to CSCs. However, the biomarkers led to the development of HNSCC stem cells remain less defined. In this study, we quantified cancer stemness by mRNA expression-based stemness index (mRNAsi), and found that mRNAsi indices were higher in HNSCC tissues than that in normal tissue. A significantly higher mRNAsi was observed in HPV positive patients than HPV negative patients, as well as in male patients than in female patients. The 8-mRNAsi signature was identified from the genes in two modules which were mostly related to mRNAsi screened by weighted gene co-expression network analysis. In this prognostic signatures, high expression of <italic>RGS16, LYVE1, hnRNPC, ANP32A</italic>, and <italic>AIMP1</italic> focus in promoting cell proliferation and tumor progression. While <italic>ZNF66, PIK3R3</italic>, and <italic>MAP2K7</italic> are associated with a low risk of death. The riskscore of eight signatures have a powerful capacity for 1-, 3-, 5-year of overall survival prediction (5-year AUC 0.77, 95% CI 0.69&#x02013;0.85). These findings based on stemness indices may provide a novel understanding of target therapy for suppressing HNSCC stem cells.</p></abstract><kwd-group><kwd>cancer cell stemness indices</kwd><kwd>head and neck squamous cell carcinomas</kwd><kwd>The Cancer Genome Atlas</kwd><kwd>weighted gene co-expression network analysis</kwd><kwd>predictive models</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content></funding-source><award-id rid="cn001">81660294</award-id><award-id rid="cn001">81602389</award-id></award-group><award-group><funding-source id="cn002">Youth Science Foundation of Jiangxi Province<named-content content-type="fundref-id">10.13039/501100010251</named-content></funding-source><award-id rid="cn002">2016BAB215249</award-id></award-group></funding-group><counts><fig-count count="8"/><table-count count="3"/><equation-count count="3"/><ref-count count="41"/><page-count count="14"/><word-count count="0"/></counts></article-meta></front><body><sec id="S1"><title>Introduction</title><p>Head and neck cancers are a collection of malignancies that arise from the upper aerodigestive tract, salivary glands and thyroid (<xref rid="B4" ref-type="bibr">Cramer et al., 2019</xref>). Head and neck squamous cell carcinomas (HNSCC) account for 90% of head and neck cancers and are mainly derived from the oral cavity, oropharynx, hypopharynx, and larynx (<xref rid="B36" ref-type="bibr">Wyss et al., 2013</xref>). The main reasons associated with their occurrence are tobacco and alcohol use, however, increased HNSCC cases with human papillomavirus (HPV) have highlighted the role of high-risk HPV in the pathology of HNSCC (<xref rid="B2" ref-type="bibr">Chaturvedi et al., 2011</xref>). Worldwide, around 430,000 patients die due to its high mortality annually, where its 5-year survival rate is about 40&#x02013;50%, though patients with the advanced disease only have a 34.9% survival rate (<xref rid="B16" ref-type="bibr">Leemans et al., 2011</xref>). Hence, it is critical to explore the mechanism regarding this malignancy, which may aid in diagnosing early HNSCC and predicting clinical outcomes.</p><p>Stem cells are known to be a cell subset having the ability to self-renew and differentiate, which has been found in most human tissues (<xref rid="B1" ref-type="bibr">Blanpain et al., 2004</xref>). Due to strides in cancer research, cancer cells are generally considered to have the propensity to initiate, spread and metastasize. Several studies based on multiple tumors showed that a small subpopulation of undifferentiated cells that strikingly resemble stem cells within the tumor could trigger cancers. Therefore, these cells were aptly named cancer stem cells (CSCs; <xref rid="B30" ref-type="bibr">Reya et al., 2001</xref>). Cancer stem cells are present in bulk tumors of HNSCC and gave rise to new tumors in immunodeficient mice (<xref rid="B28" ref-type="bibr">Prince et al., 2007</xref>; <xref rid="B21" ref-type="bibr">Okamoto et al., 2009</xref>), which may elucidate how residual stem cells cause tumor recurrence and regrowth in patients following treatment. To further clarify CSCs, researchers fused artificial intelligence and deep learning methods further to explore the features of stem cells in tumors. <xref rid="B20" ref-type="bibr">Malta et al. (2018)</xref> generated stemness indices for evaluating the degree of oncogenic dedifferentiation using a one-class logistic regression machine learning algorithm (OCLR), which may define signatures to quantify stemness. Accordingly, they extracted transcriptomic and epigenetic feature sets from non-transformed pluripotent stem cells and their differentiated progeny, eventually obtaining the two stemness indices, mDNAsi and mRNA expression-based stemness index (mRNAsi).</p><p>This study attempts to generate the stem cell-associated indices by taking advantage of both the Progenitor Cell Biology Consortium (PCBC) and The Cancer Genome Atlas (TCGA) databases, which analyzed and quantified cancer stemness in the HNSCC cohort and acquired their mRNAsi scores. Using weighted gene co-expression network analysis (WGCNA), gene modules were constructed that are closely related to the stem index. Eight mRNAsi based signatures were selected from two of these gene modules, and a risk model based on eight mRNAsi signatures was conducted to predict the prognostic risk in HNSCC patients. Finally, a functional analysis was carried out to determine the molecular mechanism&#x02019;s stemness regarding the prognosis of HNSCC patients.</p></sec><sec sec-type="materials|methods" id="S2"><title>Materials and Methods</title><sec id="S2.SS1"><title>Data Collection and Pre-processing</title><p>The CSC samples were downloaded from the PCBC R package synapser (v 0.6.61). Moreover, the raw data of gene expression and related clinical information of HNSCC patients were downloaded from the TCGA website, which included 546 RNA-Seq expression data. Additionally, 97 cases of GSE41613 data were downloaded from the Gene Expression Omnibus (GEO) website. The RNA-Seq data from TCGA-HNSCC were pre-processed as follows. Samples with expression profile information were retained, changing the Ensemble ID to Gene Symbol, while only leaving protein-coding genes. Next, the expression data of primary solid tumors and solid normal tissue samples were left. Afterward, the expression of multiple genes was chosen as the median. Finally, the overall survival (OS) data used for the survival analysis removed samples with a survival time of less than 30 days. GSE41613 data was also pre-processed, and the samples kept their expression profile information. Moreover, the unit of survival information of the sample was converted to days, and the probe was changed to the Gene Symbol. The probes which were related to several genes were deleted, and the expression of multiple genes was chosen as the median. As the TCGA data, the OS data used for the survival analysis removed samples with a survival time less than 30 days. All data from these two databases after pre-processing are shown in <xref rid="T1" ref-type="table">Table 1</xref>.</p><table-wrap id="T1" position="float"><label>TABLE 1</label><caption><p>Clinical information of TCGA-HNSCC and GSE41613.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Clinical features</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>TCGA-STAD</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>GSE41613</bold></td></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Type</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Normal</td><td valign="top" align="center" rowspan="1" colspan="1">44</td><td valign="top" align="center" rowspan="1" colspan="1">0</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Tumor</td><td valign="top" align="center" rowspan="1" colspan="1">500</td><td valign="top" align="center" rowspan="1" colspan="1">97</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>OS</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">280</td><td valign="top" align="center" rowspan="1" colspan="1">46</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">211</td><td valign="top" align="center" rowspan="1" colspan="1">50</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>OS time (mean)</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">1047.261</td><td valign="top" align="center" rowspan="1" colspan="1">1997.23</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">767.1185</td><td valign="top" align="center" rowspan="1" colspan="1">730.65</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>T Stage</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">T1</td><td valign="top" align="center" rowspan="1" colspan="1">34</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">T2</td><td valign="top" align="center" rowspan="1" colspan="1">143</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">T3</td><td valign="top" align="center" rowspan="1" colspan="1">132</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">T4</td><td valign="top" align="center" rowspan="1" colspan="1">180</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">TX</td><td valign="top" align="center" rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>N Stage</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">N0</td><td valign="top" align="center" rowspan="1" colspan="1">241</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">N1</td><td valign="top" align="center" rowspan="1" colspan="1">81</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">N2</td><td valign="top" align="center" rowspan="1" colspan="1">152</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">N3</td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">NX</td><td valign="top" align="center" rowspan="1" colspan="1">19</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>M Stage</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">M0</td><td valign="top" align="center" rowspan="1" colspan="1">475</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">M1</td><td valign="top" align="center" rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">MX</td><td valign="top" align="center" rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Stage</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">I</td><td valign="top" align="center" rowspan="1" colspan="1">25</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">II</td><td valign="top" align="center" rowspan="1" colspan="1">81</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">III</td><td valign="top" align="center" rowspan="1" colspan="1">90</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">IV</td><td valign="top" align="center" rowspan="1" colspan="1">304</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Grade</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">G1</td><td valign="top" align="center" rowspan="1" colspan="1">61</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">G2</td><td valign="top" align="center" rowspan="1" colspan="1">299</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">G3</td><td valign="top" align="center" rowspan="1" colspan="1">119</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">G4</td><td valign="top" align="center" rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GX</td><td valign="top" align="center" rowspan="1" colspan="1">19</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Gender</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Male</td><td valign="top" align="center" rowspan="1" colspan="1">367</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Female</td><td valign="top" align="center" rowspan="1" colspan="1">133</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Age</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02264;60</td><td valign="top" align="center" rowspan="1" colspan="1">244</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x0003e;60</td><td valign="top" align="center" rowspan="1" colspan="1">255</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Unknown</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Alcohol</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">332</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">157</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Unknown</td><td valign="top" align="center" rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>HPV Status</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Negative</td><td valign="top" align="center" rowspan="1" colspan="1">64</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Positive</td><td valign="top" align="center" rowspan="1" colspan="1">19</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Unknown</td><td valign="top" align="center" rowspan="1" colspan="1">417</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Tobacco</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">111</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">2</td><td valign="top" align="center" rowspan="1" colspan="1">170</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">72</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">4</td><td valign="top" align="center" rowspan="1" colspan="1">135</td><td rowspan="1" colspan="1"/></tr></tbody></table></table-wrap></sec><sec id="S2.SS2"><title>CSCs-Related Clinical Characteristics of HNSCC</title><p>The expression data of pluripotent stem cells (ESC and iPSC) from the PCBC database were analyzed, and the OCLR algorithm was utilized to predict mRNAsi. The Kruskal-Wallis test then compared the mRNAsi of normal tissue and tumor tissue or different clinical characteristics.</p></sec><sec id="S2.SS3"><title>Weighted Gene Co-expression Network Analysis</title><sec id="S2.SS3.SSS1"><title>Module Establishment</title><p>The WGCNA co-expression algorithm was utilized to acquire the co-expressed genes and co-expression modules according to the expression profiles of these genes. According to the 500 HNSCC expression data from the TCGA database, the expression profiles of the protein-coding genes were extracted. A co-expression network was constructed using WGCNA in the R package based on the TCGA datasets. A Pearson correlation matrix was built to calculate the distance of each gene.</p><p>In this study, a soft threshold of nine was selected to screen the co-expression modules. To ensure the constructed co-expression network approached the scale-free distribution, &#x003b2; = 9 was chosen. Next, the expression matrix was changed to the adjacency matrix, after which the adjacency matrix was converted into a topological overlap matrix (TOM). Average linkage hierarchical clustering was used to cluster genes based on TOM, and the minimum genome number of the gene dendrogram was 40.</p></sec><sec id="S2.SS3.SSS2"><title>Identifying mRNAsi Modules</title><p>After determining the genetic modules, the module eigengenes of each module, in turn, was calculated, and the modules were then clustered, resulting in 20 differently related modules. The relationship between each module and different clinical characteristics was also analyzed. The most positive correlation was with the blue module, while the most negative correlation was with the yellow module.</p></sec></sec><sec id="S2.SS4"><title>Functional Annotation: Gene Ontology and Kyoto Encyclopedia of Genes and Genomes Analyses</title><p>The WebGestaltR (v0.4.2) R package was adopted for the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis and Gene Ontology (GO) functional annotation to investigate the biological functions of key modules and genes. In our study, we identify over-represented GO terms in three different categories: biological processes, molecular function and cellular component, and over-represented KEGG pathway terms. Furthermore, FDR &#x0003c; 0.05 was considered to be statistically significant.</p></sec><sec id="S2.SS5"><title>Construction and Analysis of the Risk Prognosis Model</title><p>The 491 TCGA samples were random as a 0.5:0.5 ratio divided into the training and test sets as previously described (<xref rid="B34" ref-type="bibr">Wang et al., 2020</xref>). Then, using the training set samples, the genes were further identified using a univariate Cox regression analysis of the survival coxph function package in the R language, where <italic>p</italic> &#x0003c; 0.01 was used as the threshold to optimize the data. Least absolute shrinkage and selection operator (Lasso) regression analysis was then used to reduce the number of genes, resulting in 17 genes. Next, the Akaike information criterion (AIC) was utilized to optimize the data, and a total of eight genes were finally identified for further use. The corresponding eight genes were used to build a prognostic risk score model.</p><p>The formula of the risk score model is described as:</p><disp-formula id="S2.Ex1"><mml:math id="M1"><mml:mrow><mml:mrow><mml:mi>R</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mi>i</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mi>s</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mi>k</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mi>S</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mi>c</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mi>o</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mi>r</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mpadded width="+3.3pt"><mml:mi>e</mml:mi></mml:mpadded></mml:mrow><mml:mo rspace="5.8pt">=</mml:mo><mml:mrow><mml:mrow><mml:mrow><mml:msup><mml:mn>0.20799</mml:mn><mml:mo>&#x000d7;</mml:mo></mml:msup><mml:mo>&#x02062;</mml:mo><mml:mi>R</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mi>G</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mi>S</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mn>16</mml:mn></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:msup><mml:mn>0.2492</mml:mn><mml:mo>&#x000d7;</mml:mo></mml:msup><mml:mo>&#x02062;</mml:mo><mml:mi>L</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mi>Y</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mi>V</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mi>E</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mrow><mml:mo>-</mml:mo><mml:msup><mml:mn>0.8828</mml:mn><mml:mo>&#x000d7;</mml:mo></mml:msup></mml:mrow></mml:mrow></mml:math></disp-formula><disp-formula id="S2.Ex2"><mml:math id="M2"><mml:mrow><mml:mrow><mml:mpadded lspace="36pt" width="+36pt"><mml:mi>M</mml:mi></mml:mpadded><mml:mo>&#x02062;</mml:mo><mml:mi>A</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mi>P</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mn>2</mml:mn><mml:mo>&#x02062;</mml:mo><mml:mi>K</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mn>7</mml:mn></mml:mrow><mml:mo>-</mml:mo><mml:mrow><mml:msup><mml:mn>0.2654</mml:mn><mml:mo>&#x000d7;</mml:mo></mml:msup><mml:mo>&#x02062;</mml:mo><mml:mi>P</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mi>I</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mi>K</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mn>3</mml:mn><mml:mo>&#x02062;</mml:mo><mml:mi>R</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mn>3</mml:mn></mml:mrow><mml:mo>-</mml:mo><mml:mrow><mml:msup><mml:mn>0.5666</mml:mn><mml:mo>&#x000d7;</mml:mo></mml:msup><mml:mo>&#x02062;</mml:mo><mml:mi>Z</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mi>N</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mi>F</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mn>66</mml:mn></mml:mrow></mml:mrow></mml:math></disp-formula><disp-formula id="S2.Ex3"><mml:math id="M3"><mml:mrow><mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:msup><mml:mn>0.6486</mml:mn><mml:mo>&#x000d7;</mml:mo></mml:msup><mml:mo>&#x02062;</mml:mo><mml:mi>h</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mi>n</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mi>R</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mi>N</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mi>P</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mi>C</mml:mi></mml:mrow></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:msup><mml:mn>0.7821</mml:mn><mml:mo>&#x000d7;</mml:mo></mml:msup><mml:mo>&#x02062;</mml:mo><mml:mi>A</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mi>N</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mi>P</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mn>32</mml:mn><mml:mo>&#x02062;</mml:mo><mml:mi>A</mml:mi></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:msup><mml:mn>0.5284</mml:mn><mml:mo>&#x000d7;</mml:mo></mml:msup><mml:mo>&#x02062;</mml:mo><mml:mi>A</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mi>I</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mi>M</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mi>P</mml:mi><mml:mo>&#x02062;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mrow></mml:math></disp-formula><p>We used TCGA training set to test whether the gene markers were independent prognostic factors, and multivariate Cox regression analysis was used. Receiver operating characteristic (ROC) curve was depicted using the timeROC package in R. Samples in H (High) set had a significantly higher score compared to those in the L (Low) set, where &#x0201c;0&#x0201d; was used to divide the two sets. A Kaplan&#x02013;Meier (KM) curve was drawn. Significance was defined as <italic>P</italic> &#x0003c; 0.05.</p></sec><sec id="S2.SS6"><title>Module and Clinical Trait Association Prognosis Analysis</title><p>The relationship between different clinical traits and OS time survival curves were plotted from the KM estimates. For the 8-mRNAsi based signature associations, some groups were clearly distinct to high or low expression groups.</p></sec><sec id="S2.SS7"><title>Gene Set Enrichment Analysis and Gene Set Variation Analysis (GSVA)</title><p>The R package was employed to perform the gene set enrichment analysis (GSEA) analysis of the key genes. Meanwhile, the &#x0201c;gene set variation analysis (GSVA)&#x0201d; R package was used to find the most associated pathways with the 8-mRNAsi based signature. Based on the different functions according to the score of each sample, the correlation between these functions and risk was further calculated, and the most associated pathways were identified.</p></sec><sec id="S2.SS8"><title>Cell Culture</title><p>Human HNSCC cell lines FaDu, JHU011 and HN8 were kindly provided by the Xiangya Hospital of Central South University. FaDu cell was cultured in MEM medium (Sigma, MO, United States), JHU011cell was cultured in RPMI-1640 and HN8 cell was cultured in DMEM medium (Sigma, MO, United States). All the medium were supplemented with 10% FBS and 1% penicillin/streptomycin, maintained on plastic plates and incubated at 37&#x000b0;C with 5% CO<sub>2</sub>.</p></sec><sec id="S2.SS9"><title>RT-qPCR Assay</title><p>According to the manufacturer&#x02019;s protocol, total RNA of cells was extracted using TRIzol (Life Technologies, Carlsbad, CA, United States). After cDNA synthesis (All-in-One First-Strand cDNA Synthesis kit, GeneCopoeia Inc, Santa Cruz, CA, United States), the quantitative real-time polymerase chain reaction (qPCR) experiment was carried out using All-in-One qPCR Mix (GeneCopoeia Inc, United States) on ABI 7500HT System (Applied Biosystems, Foster City, CA, United States) using primers were described as <xref ref-type="supplementary-material" rid="TS1">Supplementary Table 1</xref>. The PCR detailed reaction conditions were as follows: 95&#x000b0;C for 5 min followed by 40 cycles of 95&#x000b0;C for 10 s, 60&#x000b0;C for 20 s and 72&#x000b0;C for 20 s. GAPDH was used as the internal control in this study. The relative expression of target genes was controlled to GAPDH and 2<sup>&#x02013;&#x00394;&#x00394;C<italic>T</italic></sup> method was calculated to evaluate relative mRNA levels. All the experiments were run in triplicate.</p></sec></sec><sec id="S3"><title>Results</title><sec id="S3.SS1"><title>Relationship Between mRNAsi and Clinical Characteristics in Head and Neck Cancer</title><p>mRNA expression-based stemness index is a particular stemness index, which is considered to be a biomarker in CSCs. 78 cases of expression data from pluripotent stem cells were downloaded from PCBC. Here, mRNAsi in HNSCC tissues was significantly higher than that of normal tissues (<italic>p</italic> = 0.0064) (<xref ref-type="fig" rid="F1">Figure 1A</xref>). Moreover, to discover the correlation of mRNAsi with the corresponding clinical characteristics, the downloaded information contains the gender, age, disease stage, tumor stage classification, node stage classification, clinical grade, HPV status, smoking status, and alcohol status. The result of the Kruskal&#x02013;Wallis test showed that male patients had a significantly higher mRNAsi than female patients (<italic>p</italic> = 0.022) (<xref ref-type="fig" rid="F1">Figure 1B</xref>). Meanwhile, there was a difference in mRNAsi in the smoking status group (<italic>p</italic> = 0.04) (<xref ref-type="fig" rid="F1">Figure 1J</xref>). And the result of Kruskal&#x02013;Wallis test indicated that HPV positive patients had a significantly higher mRNAsi than HPV negative patients (<italic>p</italic> = 2.5e-07) (<xref ref-type="fig" rid="F1">Figure 1E</xref>). In terms of age, alcohol status, tumor classification, node classification, and disease stage, no significant difference in the mRNAsi was present among the tumor tissues (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p><fig id="F1" position="float"><label>FIGURE 1</label><caption><p>Correlation between mRNAsi and clinical characteristics in HNSCC. <bold>(A)</bold> The different expressions of mRNAsi between normal and tumor samples. <bold>(B)</bold> The different expressions of mRNAsi between gender-specific samples. <bold>(C)</bold> The different expressions of mRNAsi between different age samples. <bold>(D)</bold> The different expressions of mRNAsi between drinking alcohol status samples. <bold>(E)</bold> The different expressions of mRNAsi between different HPV status samples. <bold>(F)</bold> The different expressions of mRNAsi between different T staging. <bold>(G)</bold> The different expressions of mRNAsi between different N staging samples. <bold>(H)</bold> The different expressions of mRNAsi between different Grade grading samples. <bold>(I)</bold> The different expressions of mRNAsi between different Stage staging samples. <bold>(J)</bold> The different expressions of mRNAsi between smoking status samples.</p></caption><graphic xlink:href="fgene-11-566159-g001"/></fig></sec><sec id="S3.SS2"><title>WGCNA: Head and Neck Cancer Stem Cell Index and Gene Expression Analysis</title><p>Weighted gene co-expression network analysis analyzes the molecular interactions according to the co-expression network (<xref rid="B33" ref-type="bibr">Tian et al., 2018</xref>). Here, the expression profiles of protein-coding genes were selected according to 500 gene expression profiles of head and neck cancer from the TCGA database. Hierarchical clustering was then used to analyze sample clustering (<xref ref-type="fig" rid="F2">Figure 2A</xref>). To this effect, &#x003b2; = 9 (<xref ref-type="fig" rid="F2">Figure 2B</xref>) was chosen as a soft scale to ensure a scale-free network, culminating with 20 gene modules for further analysis (<xref ref-type="fig" rid="F2">Figure 2C</xref>).</p><fig id="F2" position="float"><label>FIGURE 2</label><caption><p>Identify mRNAsi basedgene modules in HNSCC. <bold>(A)</bold> Cluster analysis. <bold>(B)</bold> Analysis of network topology for various soft-thresholding powers. <bold>(C)</bold> Gene dendrogram and module colors. <bold>(D)</bold> Results of correlation between twenty modules and each clinical phenotype. <bold>(E)</bold> Correlation of blue modules and genes. <bold>(F)</bold> Correlation of yellow modules and genes.</p></caption><graphic xlink:href="fgene-11-566159-g002"/></fig><p>The correlation of mRNAsi with clinical factors like gender, age, TNM classification, and clinical stage was examined, as shown in <xref ref-type="fig" rid="F2">Figure 2D</xref>, where the most significant positive correlation module with mRNAsi is the blue module, and the most negative correlation module with mRNAsi is the yellow module. And these two modules contain 1518 genes, and all the genes are shown in <xref ref-type="supplementary-material" rid="TS2">Supplementary Table 2</xref>. The module membership in the blue module was shown in <xref ref-type="fig" rid="F2">Figure 2E</xref> and the module membership in the yellow module was shown in <xref ref-type="fig" rid="F2">Figure 2F</xref>.</p></sec><sec id="S3.SS3"><title>Gene Modules Functional Annotation Analysis</title><p>This study employed GO and KEGG for the functional enrichment analysis of the blue and yellow modules. For the blue module, the study results show that all the top 10 significantly enriched factors with GO, Biological process (BP), Cellular component (CC), and KEGG pathways were obtained, as presented in <xref ref-type="supplementary-material" rid="FS1">Supplementary Figure 1</xref>. Notably, p53 signaling pathway, DNA replication and cell cycle are related to cancer, as we found in KEGG pathway analysis. Then for the yellow module, we can also get the results that the top 10 significantly enriched factors with GO, BP, CC, and KEGG pathways were presented in <xref ref-type="supplementary-material" rid="FS2">Supplementary Figure 2</xref>. Among all enriched KEGG pathways, the PI3K-Akt signaling pathway, MAPK signaling pathway and ECM&#x02013;receptor interaction are related to cancer.</p></sec><sec id="S3.SS4"><title>Construct a Gene Prognostic Risk Model Based on mRNAsi</title><sec id="S3.SS4.SSS1"><title>mRNAsi-Related Gene Prognostic Risk Models</title><p>The 491 samples were selected from TCGA and were randomly divided into training sets and test sets (<xref rid="T2" ref-type="table">Table 2</xref>). Additionally, 246 patients from the training set were used in the following survival analysis. According to the univariate Cox regression model and Lasso cox regression model, 17 genes were acquired for subsequent analysis. Afterward, AIC was used to optimize the data, and a total of eight genes were finally identified to analyze: <italic>RGS16, LYVE1, MAP2K7, PIK3R3, ZNF66, hnRNPC, ANP32A</italic>, and <italic>AIMP1</italic>.</p><table-wrap id="T2" position="float"><label>TABLE 2</label><caption><p>Clinical information statistics for TCGA train set and test set.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Clinical Features</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>TCGA-train</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>TCGA-test</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold><italic>P</italic></bold></td></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>OS</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">146</td><td valign="top" align="center" rowspan="1" colspan="1">134</td><td valign="top" align="center" rowspan="1" colspan="1">0.3417</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">100</td><td valign="top" align="center" rowspan="1" colspan="1">111</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>T Stage</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">T1</td><td valign="top" align="center" rowspan="1" colspan="1">18</td><td valign="top" align="center" rowspan="1" colspan="1">15</td><td valign="top" align="center" rowspan="1" colspan="1">0.4751</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">T2</td><td valign="top" align="center" rowspan="1" colspan="1">64</td><td valign="top" align="center" rowspan="1" colspan="1">77</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">T3</td><td valign="top" align="center" rowspan="1" colspan="1">72</td><td valign="top" align="center" rowspan="1" colspan="1">58</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">T4</td><td valign="top" align="center" rowspan="1" colspan="1">86</td><td valign="top" align="center" rowspan="1" colspan="1">91</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">TX</td><td valign="top" align="center" rowspan="1" colspan="1">6</td><td valign="top" align="center" rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>N Stage</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">N0</td><td valign="top" align="center" rowspan="1" colspan="1">112</td><td valign="top" align="center" rowspan="1" colspan="1">125</td><td valign="top" align="center" rowspan="1" colspan="1">0.4721</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">N1</td><td valign="top" align="center" rowspan="1" colspan="1">40</td><td valign="top" align="center" rowspan="1" colspan="1">39</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">N2</td><td valign="top" align="center" rowspan="1" colspan="1">82</td><td valign="top" align="center" rowspan="1" colspan="1">68</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">N3</td><td valign="top" align="center" rowspan="1" colspan="1">2</td><td valign="top" align="center" rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">NX</td><td valign="top" align="center" rowspan="1" colspan="1">10</td><td valign="top" align="center" rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>M Stage</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">M0</td><td valign="top" align="center" rowspan="1" colspan="1">233</td><td valign="top" align="center" rowspan="1" colspan="1">234</td><td valign="top" align="center" rowspan="1" colspan="1">0.396</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">M1</td><td valign="top" align="center" rowspan="1" colspan="1">4</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">MX</td><td valign="top" align="center" rowspan="1" colspan="1">9</td><td valign="top" align="center" rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Stage</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">I</td><td valign="top" align="center" rowspan="1" colspan="1">10</td><td valign="top" align="center" rowspan="1" colspan="1">15</td><td valign="top" align="center" rowspan="1" colspan="1">0.3178</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">II</td><td valign="top" align="center" rowspan="1" colspan="1">46</td><td valign="top" align="center" rowspan="1" colspan="1">34</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">III</td><td valign="top" align="center" rowspan="1" colspan="1">41</td><td valign="top" align="center" rowspan="1" colspan="1">49</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">IV</td><td valign="top" align="center" rowspan="1" colspan="1">149</td><td valign="top" align="center" rowspan="1" colspan="1">147</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Grade</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">G1</td><td valign="top" align="center" rowspan="1" colspan="1">30</td><td valign="top" align="center" rowspan="1" colspan="1">30</td><td valign="top" align="center" rowspan="1" colspan="1">0.5258</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">G2</td><td valign="top" align="center" rowspan="1" colspan="1">145</td><td valign="top" align="center" rowspan="1" colspan="1">148</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">G3</td><td valign="top" align="center" rowspan="1" colspan="1">63</td><td valign="top" align="center" rowspan="1" colspan="1">54</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">G4</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GX</td><td valign="top" align="center" rowspan="1" colspan="1">8</td><td valign="top" align="center" rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Gender</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Male</td><td valign="top" align="center" rowspan="1" colspan="1">180</td><td valign="top" align="center" rowspan="1" colspan="1">181</td><td valign="top" align="center" rowspan="1" colspan="1">0.9401</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Female</td><td valign="top" align="center" rowspan="1" colspan="1">66</td><td valign="top" align="center" rowspan="1" colspan="1">64</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Age</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02264;60</td><td valign="top" align="center" rowspan="1" colspan="1">129</td><td valign="top" align="center" rowspan="1" colspan="1">113</td><td valign="top" align="center" rowspan="1" colspan="1">0.1904</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x0003e;60</td><td valign="top" align="center" rowspan="1" colspan="1">117</td><td valign="top" align="center" rowspan="1" colspan="1">132</td><td rowspan="1" colspan="1"/></tr></tbody></table></table-wrap><p>The KM curves showed that, except for LYVE1 and PIK3R3, the remaining six genes had significantly divided the samples from the training set into two groups, high risk groups and low risk groups (<xref ref-type="fig" rid="F3">Figure 3</xref>).</p><fig id="F3" position="float"><label>FIGURE 3</label><caption><p>Kaplan&#x02013;Meier curves of eight signatures (in the TCGA training set).</p></caption><graphic xlink:href="fgene-11-566159-g003"/></fig><p>The riskscore of the training set was calculated according to the expression level of each sample, and the distribution of RS is shown in <xref ref-type="fig" rid="F4">Figure 4A</xref>. The OS time of patients with high RS was found to be significantly lower than ones with low RS. <italic>RGS16, LYVE1, hnRNPC, ANP32A</italic>, and <italic>AIMP1</italic> with high expression represent risk factors. Moreover, <italic>ZNF66, PIK3R3</italic>, and <italic>MAP2K7</italic> attained the opposite result, making them protective factors. We further applied the timeROC package to analyze the prognosis of 1-, 3-, and 5-year survival rates. Accordingly, the model was found to exhibit that 1-year AUC 0.74, 95% CI 0.66&#x02013;0.81, 3-year AUC = 0.78, 95% CI 0.72&#x02013;0.84, and 5-year AUC 0.77 95% CI 0.69&#x02013;0.85 (<xref ref-type="fig" rid="F4">Figure 4B</xref>).</p><fig id="F4" position="float"><label>FIGURE 4</label><caption><p>Performance of the 8-mRNAsi based signature model with TCGA training set. <bold>(A)</bold> Survival time, survival status and 8-genes expression of Riskscore in the training set. <bold>(B)</bold> ROC Curve and AUC of 8-gene signature Classification. <bold>(C)</bold> The KM survival curve distribution of 8-gene signature in the training set.</p></caption><graphic xlink:href="fgene-11-566159-g004"/></fig><p>Additionally, riskscore was utilized to make the zscore, where all zscore samples greater than zero were included in the high risk group, while the rest of the samples smaller than zero were divided into the low risk group. Finally, 118 high risk samples and 128 low risk samples were obtained, the survival time between high and low risk samples was significantly (<italic>p</italic> &#x0003c; 0.0001; <xref ref-type="fig" rid="F4">Figure 4C</xref>).</p></sec><sec id="S3.SS4.SSS2"><title>Risk Model Verification</title><p>To verify the robustness of the 8-mRNAsi based signature model, we calculated a riskscore in TCGA test set and an external dataset (GSE41613). Regarding the TCGA test dataset (<xref ref-type="supplementary-material" rid="FS3">Supplementary Figure 3</xref>), we found the same results as the training set was yielded for, where ROC analysis showed that the 5-year AUC was up to 0.70. The survival time between high and low risk samples was significantly different (<italic>p</italic> &#x0003c; 0.0001). For the GSE41613 database (<xref ref-type="supplementary-material" rid="FS4">Supplementary Figure 4</xref>), ROC analysis showed that the average 1-, 3-, and 5-year AUC for the 8-mRNAsi based signature was close to 0.67, 95%, the relationship between the expression of the eight genes and risk score is also consistent with the training set.</p></sec><sec id="S3.SS4.SSS3"><title>Risk Model and Analysis of Clinical Features of Prognosis</title><p>A series of KM curves graphs were made to analyze the prognosis. As shown in <xref ref-type="fig" rid="F5">Figure 5</xref>, patients with HNSCC were analyzed according to nine clinical features (tumor classification, Node classification, disease stage, grade, gender, age, alcohol status HPV status and smoking status). The meaning of the four different smoking status in <xref ref-type="fig" rid="F5">Figure 5I</xref> was as follows: Lifelong Non-smoker (less than 100 cigarettes smoked in Lifetime) = Tabacco1; Current smoker (includes daily smokers and non-daily smokers or occasional smokers) = Tabacco2; Current reformed smoker for &#x0003e; 15 years (greater than 15 years) = Tabacco3; Current reformed smoker for &#x02264;15 years (less than or equal to 15 years) = Tabacco4. The results showed that only the stage group and HPV status were related to OS time (<italic>p</italic> &#x0003c; 0.05) (<xref ref-type="fig" rid="F5">Figures 5C,H</xref>), and the prognosis was worse with increasing disease stage and with HPV negative patients.</p><fig id="F5" position="float"><label>FIGURE 5</label><caption><p>The KM curves of different clinical characteristics. <bold>(A)</bold> KM curves of different tumor classifications. <bold>(B)</bold> KM curves of different node classifications. <bold>(C)</bold> KM curves of different disease stages. <bold>(D)</bold> KM curves of different cancer grades. <bold>(E)</bold> KM curves of different genders. <bold>(F)</bold> KM curves of young (age &#x02264; 60) and elderly (age &#x0003e; 60) ages. <bold>(G)</bold> KM curves of different alcohol status. <bold>(H)</bold> KM curves of different HPV status. <bold>(I)</bold> KM curves of different smoking status.</p></caption><graphic xlink:href="fgene-11-566159-g005"/></fig><p>To further explore the influence of clinical features on the OS of the 8-mRNAsi based signature, all clinical features were stratified. Then, every stratified feature was divided into high-risk and low-risk groups. As shown in <xref ref-type="fig" rid="F6">Figure 6</xref>, the 8-mRNAsi based signature acted as a risk factor for patients with different clinical characteristics.</p><fig id="F6" position="float"><label>FIGURE 6</label><caption><p>KM curves showing the OS of each subgroup of HNSCC patients with high or low riskscores. <bold>(A)</bold> KM curves of high and low risk samples in the young (age &#x02264; 60). <bold>(B)</bold> KM curves of high and low risk samples in the elderly (age &#x0003e; 60). <bold>(C)</bold> KM curves of Female samples. <bold>(D)</bold> KM curves of Male samples. <bold>(E)</bold> T1+T2 KM curves of high and low risk samples. <bold>(F)</bold> T3+T4 KM curves of high and low risk samples. <bold>(G)</bold> N0+N1 KM curves of high and low risk samples. <bold>(H)</bold> N2+N3 KM curves of high and low risk samples. <bold>(I)</bold> Stage I+II KM curves of high and low risk samples. <bold>(J)</bold> Stage III+IV KM curves of high and low risk samples. <bold>(K)</bold> G1+G2 KM curves of high and low risk samples. <bold>(L)</bold> G3+G4 KM curves of high and low risk samples. <bold>(M)</bold> KM curves of drinking samples. <bold>(N)</bold> KM curves of non-drinking samples. <bold>(O)</bold> KM curves of HPV negative samples. <bold>(P)</bold> KM curves of HPV positive samples. <bold>(Q)</bold> Tabacco1 KM curves of high and low risk samples. <bold>(R)</bold> Tabacco2+3+4 KM curves of high and low risk samples.</p></caption><graphic xlink:href="fgene-11-566159-g006"/></fig><p>We performed univariable and multivariable Cox regression analysis to evaluate the 8-mRNAsi based signature related HR, 95% CI of HR, <italic>P</italic>-value. Clinical characteristics, including alcohol status, age, tumor stage classification, node stage classification, pathological grade, disease stage, and riskscore, were systematically analyzed. Our results from the TCGA database showed that riskscore from either univariable (HR = 1.913, 95% CI 1.642-2.228, <italic>p</italic> = 2.0E-16) or multivariable Cox regression analysis(<italic>HR</italic> = 1.872, 95% CI 1.613-2.173, <italic>p</italic> = 2.0E-16) are significantly correlated to survival (<xref rid="T3" ref-type="table">Table 3</xref>). And the same result can be obtained in node stage classification and disease stage. In node stage classification group, univariable (HR = 1.205, 95% CI 1.045-1.389, <italic>p</italic> = 0.010) or multivariable Cox regression analysis (HR = 1.195, 95% CI 1.015-1.406, <italic>p</italic> = 0.032) are correlated to survival (<xref rid="T3" ref-type="table">Table 3</xref>). Meanwhile, in disease stage group, univariable (HR = 1.345, 95% CI 1.138-1.589, <italic>p</italic> = 5.0E-04) or multivariable Cox regression analysis (HR = 1.310, 95% CI 1.056-1.625, <italic>p</italic> = 0.014) are significantly correlated to survival (<xref rid="T3" ref-type="table">Table 3</xref>).</p><table-wrap id="T3" position="float"><label>TABLE 3</label><caption><p>Univariate and multivariate COX regression analyses of clinical factors.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Variables</bold></td><td valign="top" align="center" colspan="4" rowspan="1"><bold>Univariable analysis</bold><hr/></td><td valign="top" align="center" colspan="4" rowspan="1"><bold>Multivariable analysis</bold><hr/></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"><bold>HR</bold></td><td valign="top" align="center" colspan="2" rowspan="1"><bold>95% CI of HR</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold><italic>P</italic></bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>HR</bold></td><td valign="top" align="center" colspan="2" rowspan="1"><bold>95% CI of HR</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold><italic>P</italic></bold></td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"><bold>Lower</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>Upper</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"><bold>Lower</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>Upper</bold></td><td rowspan="1" colspan="1"/></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Age</td><td valign="top" align="center" rowspan="1" colspan="1">1.017</td><td valign="top" align="center" rowspan="1" colspan="1">1.005</td><td valign="top" align="center" rowspan="1" colspan="1">1.030</td><td valign="top" align="center" rowspan="1" colspan="1">0.007</td><td valign="top" align="center" rowspan="1" colspan="1">1.022</td><td valign="top" align="center" rowspan="1" colspan="1">1.008</td><td valign="top" align="center" rowspan="1" colspan="1">1.035</td><td valign="top" align="center" rowspan="1" colspan="1">0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Alcohol</td><td valign="top" align="center" rowspan="1" colspan="1">1.025</td><td valign="top" align="center" rowspan="1" colspan="1">0.792</td><td valign="top" align="center" rowspan="1" colspan="1">1.326</td><td valign="top" align="center" rowspan="1" colspan="1">0.850</td><td valign="top" align="center" rowspan="1" colspan="1">0.927</td><td valign="top" align="center" rowspan="1" colspan="1">0.710</td><td valign="top" align="center" rowspan="1" colspan="1">1.212</td><td valign="top" align="center" rowspan="1" colspan="1">0.581</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">T</td><td valign="top" align="center" rowspan="1" colspan="1">1.099</td><td valign="top" align="center" rowspan="1" colspan="1">0.962</td><td valign="top" align="center" rowspan="1" colspan="1">1.256</td><td valign="top" align="center" rowspan="1" colspan="1">0.164</td><td valign="top" align="center" rowspan="1" colspan="1">0.907</td><td valign="top" align="center" rowspan="1" colspan="1">0.776</td><td valign="top" align="center" rowspan="1" colspan="1">1.059</td><td valign="top" align="center" rowspan="1" colspan="1">0.216</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">N</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>1.205</bold></td><td valign="top" align="center" rowspan="1" colspan="1">1.045</td><td valign="top" align="center" rowspan="1" colspan="1">1.389</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>0.010</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>1.195</bold></td><td valign="top" align="center" rowspan="1" colspan="1">1.015</td><td valign="top" align="center" rowspan="1" colspan="1">1.406</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>0.032</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Grade</td><td valign="top" align="center" rowspan="1" colspan="1">1.096</td><td valign="top" align="center" rowspan="1" colspan="1">0.915</td><td valign="top" align="center" rowspan="1" colspan="1">1.313</td><td valign="top" align="center" rowspan="1" colspan="1">0.318</td><td valign="top" align="center" rowspan="1" colspan="1">1.051</td><td valign="top" align="center" rowspan="1" colspan="1">0.867</td><td valign="top" align="center" rowspan="1" colspan="1">1.274</td><td valign="top" align="center" rowspan="1" colspan="1">0.612</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Stage</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>1.345</bold></td><td valign="top" align="center" rowspan="1" colspan="1">1.138</td><td valign="top" align="center" rowspan="1" colspan="1">1.589</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>5.0E-04</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>1.310</bold></td><td valign="top" align="center" rowspan="1" colspan="1">1.056</td><td valign="top" align="center" rowspan="1" colspan="1">1.625</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>0.014</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">RiskScore</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>1.913</bold></td><td valign="top" align="center" rowspan="1" colspan="1">1.642</td><td valign="top" align="center" rowspan="1" colspan="1">2.228</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>2.0E-16</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>1.872</bold></td><td valign="top" align="center" rowspan="1" colspan="1">1.613</td><td valign="top" align="center" rowspan="1" colspan="1">2.173</td><td valign="top" align="center" rowspan="1" colspan="1"><bold>2.0E-16</bold></td></tr></tbody></table></table-wrap></sec></sec><sec id="S3.SS5"><title>Relationship Between Riskscore and Signaling Pathway</title><p>To analyze the KEGG functional enrichment score for each sample in the training set, GSVA was utilized in the R software package for the GSEA analysis.</p><p>The scores were calculated from each sample with different functions to acquire the ssGSEA score of each function corresponding to each sample, where the relationship between functions and riskscore was further verified. The function with a correlation greater than 0.25 was selected, as shown in <xref ref-type="fig" rid="F7">Figure 7A</xref>.</p><fig id="F7" position="float"><label>FIGURE 7</label><caption><p>GSVA-derived clustering heatmaps of different pathways. <bold>(A)</bold> Clustering of correlation coefficients between KEGG pathways and RiskScore with a correlation greater than 0.25 with risk scores. <bold>(B)</bold> The correlation between the KEGG pathway and the risk score is greater than 0.25, and the ssGSEA score in each sample changes with the increase in risk score. The horizontal axis represents the sample, and the risk score increases in turn from left to right.</p></caption><graphic xlink:href="fgene-11-566159-g007"/></fig><p>Here, 13 cases had a positively correlated with the sample risk score, while two had a negative correlation. The most related ten KEGG pathways were chosen and were clustered based on their enrichment score (<xref ref-type="fig" rid="F7">Figure 7B</xref>). Accordingly, among all pathways, the riskscore rises as KEGG_COMPLEMENT_AND_COAGULATION_CASCADES, KEGG_NITROGEN_METABOLISM, and KEGG_TGF_BETA_ SIGNALING_PATHWAY rises, and for KEGG_REGULATION_ OF_AUTOPHAGY, KEGG_TASTE_TRANSDUCTION, KEGG _ABC_TRANSPORTERS, the riskscore decreases as they increase.</p></sec><sec id="S3.SS6"><title>Expression Level of Eight mRNAsi in HNSCC Cell Lines as Detected by a RT-qPCR Assay</title><p>We tested the expression levels of eight mRNAsi in FaDu, JHU011, and HN8 cell lines by a RT-qPCR assay. The results showed that <italic>RGS16</italic>, <italic>LYVE1, hnRNPC, ANP32A and A1MP1</italic> were highly expressed in all cell lines. And <italic>ZNF66, PIK3R3 and MAP2K7</italic> were lowly expressed in three cell lines (<xref ref-type="fig" rid="F8">Figure 8</xref>).</p><fig id="F8" position="float"><label>FIGURE 8</label><caption><p>The transcriptional expression level of eight mRNAsi in HNSCC cell lines.</p></caption><graphic xlink:href="fgene-11-566159-g008"/></fig></sec></sec><sec id="S4"><title>Discussion</title><p>Many advanced therapeutic and diagnostic methods have been carried out in modern HNSCC treatment, though their effects remain inadequate as the oncologists anticipated. CSCs, due to their strong self-renewal ability, are thought to play an essential role associated with invasive potential, tumor growth and therapeutic resistance in response to the development of HNSCC (<xref rid="B26" ref-type="bibr">Peitzsch et al., 2019</xref>). Therefore, identifying therapeutic targets for CSCs would be significant in anti-cancer treatment. As a type of heterogeneous malignancy, a molecular analysis of HNSCC tissues demonstrates high intratumoral heterogeneity determined by clonal evolution of the CSCs populations (<xref rid="B38" ref-type="bibr">Yang et al., 2020</xref>). In the present study, the correlation of mRNAsi indices between normal tissues and HNSCC tissues were presented based on the OCLR machine-learning algorithm (<xref rid="B20" ref-type="bibr">Malta et al., 2018</xref>). In line with previous studies regarding other cancers (<xref rid="B20" ref-type="bibr">Malta et al., 2018</xref>; <xref rid="B18" ref-type="bibr">Lian et al., 2019</xref>), a significantly higher level of mRNAsi was observed in HNSCC tissues compared to that in normal tissues. By comparing the mRNAsi with the clinical characteristics, which revealed that mRNAsi had a significant rise in HPV positive patients, and that male patients had a higher mRNAsi indices than female patients. This result may suggest a potential correlation of HPV status with CSCs. One study of four HPV negative HNSCC cell lines were infected with HPV genome, which resulted in tumor cells have increased growth and self-renewal capacity (<xref rid="B15" ref-type="bibr">Lee et al., 2015</xref>). Zhang reported a study of six oropharyngeal HNSCC tumor specimens, where HPV positive tumors had a higher proportion of CSCs compared to HPV negative tumors in six specimens of HNSCC, which was attributed to p53 inactivation by HPV (<xref rid="B39" ref-type="bibr">Zhang et al., 2014</xref>). P53 is an essential target of HPV-E6/E7 proteins that bind to p53 resulting in the deregulation of p53 and causing a more proliferative state (<xref rid="B10" ref-type="bibr">Jin and Xu, 2015</xref>). Conversely, Tang determined that CSCs population are not affected by HPV in HNSCC (<xref rid="B32" ref-type="bibr">Tang et al., 2013</xref>). These databases suggested that the current understanding of the relationship between HPV status and CSCs is still weak. It will be interesting to perform additional research for the underlying mechanism.</p><p>By applying WGCNA, an important system in bioinformatics used to generate gene co-expression networks to detect gene modules and identify key genes (<xref rid="B13" ref-type="bibr">Langfelder and Horvath, 2008</xref>; <xref rid="B17" ref-type="bibr">Li et al., 2018</xref>), gene modules that were correlated with mRNAsi indices based on the gene expression profile of HNSCC samples were initially identified. In these modules, blue one had the most considerable positive correlation with mRNAsi indices, while yellow one had the opposite. Functional annotation could be beneficial in evaluating the impact of these gene modules on HNSCC. Regarding the blue module, major biological processes were involved in regulating the mitotic phase, organelle fission and negative regulation of the cell cycle. KEGG enrichment pathways in the blue module encompassed DNA replication, p53 signaling pathway and the cell cycle. KEGG enrichment pathways in the yellow module were mainly involved in ECM&#x02013;receptor interactions, PI3K-Akt signaling pathways, and MAPK signaling pathways. These signaling pathways have been demonstrated to facilitate cell survival, self-renewal and apoptosis inhibition in many CSCs (<xref rid="B7" ref-type="bibr">Huang et al., 2017</xref>; <xref rid="B3" ref-type="bibr">Chen et al., 2020</xref>; <xref rid="B19" ref-type="bibr">Liao et al., 2020</xref>; <xref rid="B29" ref-type="bibr">Qin et al., 2020</xref>).</p><p>Key genes selected from mRNAsi correlated modules are currently employed in practice. <xref rid="B22" ref-type="bibr">Pan et al. (2019)</xref> screened 13 key genes based on mRNAsi associated gene modules in bladder cancer, which was shown to be related to stem cells. <xref rid="B25" ref-type="bibr">Pei et al. (2020)</xref> selected 12 mRNAsi based genes to be correlated with the survival of breast cancer patients. <xref rid="B40" ref-type="bibr">Zhang et al. (2020)</xref> showed 13 genes enriched in the cell cycle, which were increased due to the pathological stages of lung adenocarcinoma. These studies signified that there are inextricable links between key gene expressions and OS of patients. However, substantial evidence demonstrating that key genes may have predictive features in the clinical characteristics of cancer patients not yet elucidated. In the present study, 8-mRNAsi based signatures were established in predicting HNSCC. The riskscore was generated in samples of HNSCC based on expression patterns of these eight genes, which can serve as an independent predictor for OS in HNSCC patients (<xref rid="T2" ref-type="table">Table 2</xref>). The 8-mRNAsi based signature may also easily divide the HNSCC samples into high risk and low risk groups according to their various clinical characteristics required in the prognostic model for its potential use in clinical practice. Similar to our work, Cao and collaborators have evaluated the correlation between a three lncRNA signature patients OS with HNSCC by a log-rank test and univariable Cox regression. By OPLS-DA analysis and fold change selection, the three lncRNA signatures that can categorize patients into high and low risk groups have the highest predictive capacity. Comparatively, the same point is that univariable and multivariable Cox regression analysis were used to select the related genes in both studies. Otherwise, WGCNA and Lasso were performed in our study as the methods of dimensionality reduction for analyzing and selecting CSCs associated mRNA in HNSCC patients.</p><p>The 8-mRNAsi based prognostic model in our signatures includes <italic>RGS16, LYVE1, hnRNPC, ANP32A, AIMP1, ZNF66, PIK3R3</italic>, and <italic>MAP2K7</italic>, in which several genes have been reported to be linked with stemness features or be involved in cancer progression. <italic>LYVE1</italic>, lymphatic vessel endothelial hyaluronan receptor-1, has been identified as a biomarker of yolk sac endothelium and definitive hematopoietic stem and progenitor cells (HSPCs) by <italic>Lyve1-Cre</italic> labeling, where most HSPCs and erythro-myeloid progenitors were <italic>Lyve1-Cre</italic> lineage traced (<xref rid="B14" ref-type="bibr">Lee et al., 2016</xref>). <italic>LYVE1</italic> was thought to contribute to lymphangiogenesis in malignant tumors (<xref rid="B9" ref-type="bibr">Jackson et al., 2001</xref>). In the development of human embryonic stem cells, heterogeneous nuclear ribonucleoproteins (hnRNPs) has been identified as a critical regulator of physiologically relevant alternative cleavage and polyadenylation (APA) events that contribute to carcinogenesis by modulating the expression of genes that regulate cell proliferation and metastasis (<xref rid="B5" ref-type="bibr">Fischl et al., 2019</xref>). Silencing of hnRNPC can inhibit migratory and invasive activities by promoting miRNA-21 in brain tumor cells. Increased <italic>hnRNPC</italic> has been shown to contribute to cancer stemness and invasive potential in cancers (<xref rid="B24" ref-type="bibr">Park et al., 2012</xref>; <xref rid="B12" ref-type="bibr">Kleemann et al., 2018</xref>; <xref rid="B35" ref-type="bibr">Wu et al., 2018</xref>). However, the exact molecular function of <italic>hnRNPC</italic> needs to be explored in cancer stemness. <italic>ANP32A</italic>, acidic leucine-rich nuclear phosphoprotein-32A, expressed in normal tissue as well as multiple malignant tumors, several recent studies have indicated that <italic>ANP32A</italic> plays a significant role in cell proliferation, signal transduction, and other biological processes. Overexpression of <italic>ANP32A</italic> was associated with lymph node metastasis, which predicted poor survival in oral squamous cell carcinoma (OSCC) patients. Mechanical study indicates that <italic>ANP32A</italic> promotes tumor cell growth and may involve the inactivation of p38 and phosphorylation of Akt (<xref rid="B37" ref-type="bibr">Yan et al., 2017</xref>). <italic>AIMP1</italic> was identified as a cytokine that secretes in response to hypoxia and cytokine stimulation for involving cell proliferation regulation. A series of studies have shown that <italic>AIMP1</italic> can enhance wound healing by the mediation of fibroblast proliferation via ERK, and N-terminal domain (amino acids 6&#x02013;46) of <italic>AIMP1</italic> was responsible for the stimulation of fibroblast proliferation (<xref rid="B23" ref-type="bibr">Park et al., 2005</xref>; <xref rid="B6" ref-type="bibr">Han et al., 2006</xref>). <italic>AIMP1</italic> peptide increased the expression of cyclin D1 and c-myc by stabilizing &#x003b2;-catenin through FGF receptor 2 (FGFR2)-mediated activation of Akt, which promotes the proliferation of bone marrow-derived mesenchymal stem cells (<xref rid="B11" ref-type="bibr">Kim et al., 2013</xref>). <italic>ZNF66</italic> is a member of the zinc finger transcription factor family which encounters many members and the gene coding for this protein is located on chromosome 19 in a fragile site region. Low mRNA expression of <italic>ZNF66</italic> is shown in head and neck cancers according to the TCGA dataset.<sup><xref ref-type="fn" rid="footnote1">1</xref></sup> However, the correlations between the features of CSCs and <italic>ZNF66</italic> is still unclear, and additional studies need to be performed to explore the role of <italic>ZNF66</italic> in the stemness of HNSCC. <italic>PIK3R3</italic> is one of the regulatory subunits of <italic>PI3K</italic> that positively correlates with cell proliferation signatures (<xref rid="B27" ref-type="bibr">Phillips et al., 2006</xref>). Furthermore, the expression of <italic>PIK3R3</italic> increased in neoplastic tissues compared to non neoplastic in patients with gastric cancer (<xref rid="B41" ref-type="bibr">Zhou et al., 2012</xref>). However, higher expression of <italic>PIK3R3</italic> has been reported in cancer patients with satisfactory colorectal cancer outcomes as it facilitated the apoptosis of cancer cells (<xref rid="B8" ref-type="bibr">Ibrahim et al., 2018</xref>). <italic>MAP2K7</italic> is a mitogen-activated protein kinase, encodes <italic>MMK7</italic> and acts through the <italic>JNK</italic> pathway for cell cycle arrest and suppression of epithelial cancers (<xref rid="B31" ref-type="bibr">Schramek et al., 2011</xref>).</p><p>The robustness of the 8-mRNAsi based signature was validated across the TCGA test set and an external data set (GSE41613). Although these findings have been validated in HNSCC cell lines, further validation is still required in matched tissues of HNSCC patients. Additionally, the molecular process and signaling pathway obtained across the TCGA cases alone are inadequate and need to be confirmed through further investigation.</p></sec><sec id="S5"><title>Conclusion</title><p>In our eight mRNAsi based signature, high expression of <italic>RGS16, LYVE1, hnRNPC, ANP32A</italic>, and <italic>AIMP1</italic> are correlated with a high risk of death as these genes focus in promoting cell proliferation and tumor progression, similar to stem cells. Regarding the other three genes, higher expression levels of <italic>ZNF66, PIK3R3</italic>, and <italic>MAP2K7</italic> are associated with a low risk of death. Interestingly, the molecular functions of these genes mainly concentrate on repressing the cell cycle and fostering apoptosis. Moreover, the present GSEA analysis discovered the mechanism regarding the KEGG pathway, which underlies the riskscore of the 8-mRNAsi based signature. Accordingly, to the best of our knowledge, all genes in the proposed mRNAsi based prognostic model have not been studied in HNSCC and may offer insight into the development of targeted therapies for HNSCC.</p></sec><sec sec-type="data-availability" id="S6"><title>Data Availability Statement</title><p>All datasets presented in this study are included in the article/<xref ref-type="supplementary-material" rid="FS1">Supplementary Material</xref>.</p></sec><sec id="S7"><title>Author Contributions</title><p>YT designed the study and analyzed the data. JW and YT carried out the manuscript. YT and CQ prepared the figures and tables. GZ, XC, ZC, YQ, MW, and ZL co-contributed to revising and polishing the manuscript. GC, XZ, and YL collated the data and supervised the study. All authors have read and approved the final submitted manuscript.</p></sec><sec id="conf1"><title>Conflict of Interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This work was supported by The Natural Science Foundation of China (nos. 81660294 and 81602389) and The Natural Science Youth Founds of Jiangxi Province (no. 2016BAB215249).</p></fn></fn-group><fn-group><fn id="footnote1"><label>1</label><p><ext-link ext-link-type="uri" xlink:href="https://www.proteinatlas.org">https://www.proteinatlas.org</ext-link></p></fn></fn-group><sec id="S9" sec-type="supplementary material"><title>Supplementary Material</title><p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fgene.2020.566159/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fgene.2020.566159/full#supplementary-material</ext-link></p><supplementary-material content-type="local-data" id="FS1"><label>Supplementary Figure 1</label><caption><p>GO and KEGG pathway enrichment analysis in the blue module.</p></caption><media xlink:href="Image_1.TIF"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="FS2"><label>Supplementary Figure 2</label><caption><p>GO and KEGG pathway enrichment analysis in the yellow module.</p></caption><media xlink:href="Image_2.TIF"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="FS3"><label>Supplementary Figure 3</label><caption><p>Performance of the 8-mRNAsi based signature modelwith TCGA test dataset.</p></caption><media xlink:href="Image_3.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="FS4"><label>Supplementary Figure 4</label><caption><p>Performance of the 8-mRNAsi based signature modelwithGSE41613 database.</p></caption><media xlink:href="Image_4.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="TS1"><label>Supplementary Table 1</label><caption><p>The sequence of primers used for PCR in this study.</p></caption><media xlink:href="Table_1.DOCX"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="TS2"><label>Supplementary Table 2</label><caption><p>1518 genes information from yellow and blue modules.</p></caption><media xlink:href="Table_2.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanpain</surname><given-names>C.</given-names></name><name><surname>Lowry</surname><given-names>W. E.</given-names></name><name><surname>Geoghegan</surname><given-names>A.</given-names></name><name><surname>Polak</surname><given-names>L.</given-names></name><name><surname>Fuchs</surname><given-names>E.</given-names></name></person-group> (<year>2004</year>). <article-title>Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche.</article-title>
<source><italic>Cell</italic></source>
<volume>118</volume>
<fpage>635</fpage>&#x02013;<lpage>648</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2004.08.012</pub-id>
<?supplied-pmid 15339667?><pub-id pub-id-type="pmid">15339667</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaturvedi</surname><given-names>A. K.</given-names></name><name><surname>Engels</surname><given-names>E. A.</given-names></name><name><surname>Pfeiffer</surname><given-names>R. M.</given-names></name><name><surname>Hernandez</surname><given-names>B. Y.</given-names></name><name><surname>Xiao</surname><given-names>W.</given-names></name><name><surname>Kim</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Human papillomavirus and rising oropharyngeal cancer incidence in the United States.</article-title>
<source><italic>J. Clin. Oncol.</italic></source>
<volume>29</volume>
<fpage>4294</fpage>&#x02013;<lpage>4301</lpage>.<pub-id pub-id-type="pmid">21969503</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Deng</surname><given-names>G.</given-names></name><name><surname>Fu</surname><given-names>Y.</given-names></name><name><surname>Han</surname><given-names>Y.</given-names></name><name><surname>Guo</surname><given-names>C.</given-names></name><name><surname>Yin</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>FOXC2 Promotes Oxaliplatin Resistance by Inducing Epithelial-Mesenchymal Transition via MAPK/ERK Signaling in Colorectal Cancer.</article-title>
<source><italic>Onco. Targets Ther.</italic></source>
<volume>13</volume>
<fpage>1625</fpage>&#x02013;<lpage>1635</lpage>. <pub-id pub-id-type="doi">10.2147/ott.s241367</pub-id>
<?supplied-pmid 32110058?><pub-id pub-id-type="pmid">32110058</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cramer</surname><given-names>J. D.</given-names></name><name><surname>Burtness</surname><given-names>B.</given-names></name><name><surname>Le</surname><given-names>Q. T.</given-names></name><name><surname>Ferris</surname><given-names>R. L.</given-names></name></person-group> (<year>2019</year>). <article-title>The changing therapeutic landscape of head and neck cancer.</article-title>
<source><italic>Nat. Rev. Clin. Oncol.</italic></source>
<volume>16</volume>
<fpage>669</fpage>&#x02013;<lpage>683</lpage>. <pub-id pub-id-type="doi">10.1038/s41571-019-0227-z</pub-id>
<?supplied-pmid 31189965?><pub-id pub-id-type="pmid">31189965</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischl</surname><given-names>H.</given-names></name><name><surname>Neve</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Patel</surname><given-names>R.</given-names></name><name><surname>Louey</surname><given-names>A.</given-names></name><name><surname>Tian</surname><given-names>B.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>hnRNPC regulates cancer-specific alternative cleavage and polyadenylation profiles.</article-title>
<source><italic>Nucl. Acids Res.</italic></source>
<volume>47</volume>
<fpage>7580</fpage>&#x02013;<lpage>7591</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkz461</pub-id>
<?supplied-pmid 31147722?><pub-id pub-id-type="pmid">31147722</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>J. M.</given-names></name><name><surname>Park</surname><given-names>S. G.</given-names></name><name><surname>Lee</surname><given-names>Y.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name></person-group> (<year>2006</year>). <article-title>Structural separation of different extracellular activities in aminoacyl-tRNA synthetase-interacting multi-functional protein, p43/AIMP1.</article-title>
<source><italic>Biochem. Biophys. Res. Commun.</italic></source>
<volume>342</volume>
<fpage>113</fpage>&#x02013;<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2006.01.117</pub-id>
<?supplied-pmid 16472771?><pub-id pub-id-type="pmid">16472771</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>Tao</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Chang</surname><given-names>S.</given-names></name><name><surname>Jiang</surname><given-names>B.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Bioinformatics analysis of key genes and latent pathway interactions based on the anaplastic thyroid carcinoma gene expression profile.</article-title>
<source><italic>Oncol. Lett.</italic></source>
<volume>13</volume>
<fpage>167</fpage>&#x02013;<lpage>176</lpage>. <pub-id pub-id-type="doi">10.3892/ol.2016.5447</pub-id>
<?supplied-pmid 28428828?><pub-id pub-id-type="pmid">28428828</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibrahim</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>G.</given-names></name><name><surname>Hu</surname><given-names>F.</given-names></name><name><surname>Hou</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>Q.</given-names></name><name><surname>Li</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>PIK3R3 promotes chemotherapeutic sensitivity of colorectal cancer through PIK3R3/NF-kB/TP pathway.</article-title>
<source><italic>Cancer Biol. Ther.</italic></source>
<volume>19</volume>
<fpage>222</fpage>&#x02013;<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1080/15384047.2017.1416936</pub-id>
<?supplied-pmid 29370570?><pub-id pub-id-type="pmid">29370570</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>D. G.</given-names></name><name><surname>Prevo</surname><given-names>R.</given-names></name><name><surname>Clasper</surname><given-names>S.</given-names></name><name><surname>Banerji</surname><given-names>S.</given-names></name></person-group> (<year>2001</year>). <article-title>LYVE-1, the lymphatic system and tumor lymphangiogenesis.</article-title>
<source><italic>Trends Immunol.</italic></source>
<volume>22</volume>
<fpage>317</fpage>&#x02013;<lpage>321</lpage>. <pub-id pub-id-type="doi">10.1016/s1471-4906(01)01936-6</pub-id><pub-id pub-id-type="pmid">11377291</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>L.</given-names></name><name><surname>Xu</surname><given-names>Z. X.</given-names></name></person-group> (<year>2015</year>). <article-title>Recent advances in the study of HPV-associated carcinogenesis.</article-title>
<source><italic>Virol. Sin.</italic></source>
<volume>30</volume>
<fpage>101</fpage>&#x02013;<lpage>106</lpage>. <pub-id pub-id-type="doi">10.1007/s12250-015-3586-3</pub-id>
<?supplied-pmid 25910482?><pub-id pub-id-type="pmid">25910482</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S. Y.</given-names></name><name><surname>Son</surname><given-names>W. S.</given-names></name><name><surname>Park</surname><given-names>M. C.</given-names></name><name><surname>Kim</surname><given-names>C. M.</given-names></name><name><surname>Cha</surname><given-names>B. H.</given-names></name><name><surname>Yoon</surname><given-names>K. J.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>ARS-interacting multi-functional protein 1 induces proliferation of human bone marrow-derived mesenchymal stem cells by accumulation of &#x003b2;-catenin via fibroblast growth factor receptor 2-mediated activation of Akt.</article-title>
<source><italic>Stem Cells Dev.</italic></source>
<volume>22</volume>
<fpage>2630</fpage>&#x02013;<lpage>2640</lpage>. <pub-id pub-id-type="doi">10.1089/scd.2012.0714</pub-id>
<?supplied-pmid 23672191?><pub-id pub-id-type="pmid">23672191</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleemann</surname><given-names>M.</given-names></name><name><surname>Schneider</surname><given-names>H.</given-names></name><name><surname>Unger</surname><given-names>K.</given-names></name><name><surname>Sander</surname><given-names>P.</given-names></name><name><surname>Schneider</surname><given-names>E. M.</given-names></name><name><surname>Fischer-Posovszky</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>MiR-744-5p inducing cell death by directly targeting HNRNPC and NFIX in ovarian cancer cells.</article-title>
<source><italic>Sci. Rep.</italic></source>
<volume>8</volume>:<issue>9020</issue>.</mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langfelder</surname><given-names>P.</given-names></name><name><surname>Horvath</surname><given-names>S.</given-names></name></person-group> (<year>2008</year>). <article-title>WGCNA: an R package for weighted correlation network analysis.</article-title>
<source><italic>BMC Bioinform.</italic></source>
<volume>9</volume>:<issue>559</issue>. <pub-id pub-id-type="doi">10.1186/1471-2105-9-559</pub-id>
<?supplied-pmid 19114008?><pub-id pub-id-type="pmid">19114008</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>L. K.</given-names></name><name><surname>Ghorbanian</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Kim</surname><given-names>Y. J.</given-names></name><name><surname>Weissman</surname><given-names>I. L.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>LYVE1 Marks the Divergence of Yolk Sac Definitive Hemogenic Endothelium from the Primitive Erythroid Lineage.</article-title>
<source><italic>Cell Rep.</italic></source>
<volume>17</volume>
<fpage>2286</fpage>&#x02013;<lpage>2298</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2016.10.080</pub-id>
<?supplied-pmid 27880904?><pub-id pub-id-type="pmid">27880904</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S. H.</given-names></name><name><surname>Lee</surname><given-names>C. R.</given-names></name><name><surname>Rigas</surname><given-names>N. K.</given-names></name><name><surname>Kim</surname><given-names>R. H.</given-names></name><name><surname>Kang</surname><given-names>M. K.</given-names></name><name><surname>Park</surname><given-names>N. H.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Human papillomavirus 16 (HPV16) enhances tumor growth and cancer stemness of HPV-negative oral/oropharyngeal squamous cell carcinoma cells via miR-181 regulation.</article-title>
<source><italic>Papillomavir. Res.</italic></source>
<volume>1</volume>
<fpage>116</fpage>&#x02013;<lpage>125</lpage>. <pub-id pub-id-type="doi">10.1016/j.pvr.2015.08.001</pub-id>
<?supplied-pmid 26693182?><pub-id pub-id-type="pmid">26693182</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leemans</surname><given-names>C. R.</given-names></name><name><surname>Braakhuis</surname><given-names>B. J.</given-names></name><name><surname>Brakenhoff</surname><given-names>R. H.</given-names></name></person-group> (<year>2011</year>). <article-title>The molecular biology of head and neck cancer.</article-title>
<source><italic>Nat. Rev. Cancer</italic></source>
<volume>11</volume>
<fpage>9</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="pmid">21160525</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Zhou</surname><given-names>D.</given-names></name><name><surname>Qiu</surname><given-names>W.</given-names></name><name><surname>Shi</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>J. J.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Application of Weighted Gene Co-expression Network Analysis for Data from Paired Design.</article-title>
<source><italic>Sci. Rep.</italic></source>
<volume>8</volume>:<issue>622</issue>.</mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lian</surname><given-names>H.</given-names></name><name><surname>Han</surname><given-names>Y. P.</given-names></name><name><surname>Zhang</surname><given-names>Y. C.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Yan</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>Q. F.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Integrative analysis of gene expression and DNA methylation through one-class logistic regression machine learning identifies stemness features in medulloblastoma.</article-title>
<source><italic>Mol. Oncol.</italic></source>
<volume>13</volume>
<fpage>2227</fpage>&#x02013;<lpage>2245</lpage>. <pub-id pub-id-type="doi">10.1002/1878-0261.12557</pub-id>
<?supplied-pmid 31385424?><pub-id pub-id-type="pmid">31385424</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>S.</given-names></name><name><surname>Liang</surname><given-names>L.</given-names></name><name><surname>Yue</surname><given-names>C.</given-names></name><name><surname>He</surname><given-names>J.</given-names></name><name><surname>He</surname><given-names>Z.</given-names></name><name><surname>Jin</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>CD38 is involved in cell energy metabolism via activating the PI3K/AKT/mTOR signaling pathway in cervical cancer cells.</article-title>
<source><italic>Int. J. Oncol.</italic></source>
<volume>57</volume>(1), <fpage>338</fpage>&#x02013;<lpage>354</lpage>. <pub-id pub-id-type="doi">10.3892/ijo.2020.5040</pub-id>
<?supplied-pmid 32319590?><pub-id pub-id-type="pmid">32319590</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malta</surname><given-names>T. M.</given-names></name><name><surname>Sokolov</surname><given-names>A.</given-names></name><name><surname>Gentles</surname><given-names>A. J.</given-names></name><name><surname>Burzykowski</surname><given-names>T.</given-names></name><name><surname>Poisson</surname><given-names>L.</given-names></name><name><surname>Weinstein</surname><given-names>J. N.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation.</article-title>
<source><italic>Cell</italic></source>
<volume>173</volume>
<fpage>338</fpage>&#x02013;<lpage>354.e</lpage>.<pub-id pub-id-type="pmid">29625051</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okamoto</surname><given-names>A.</given-names></name><name><surname>Chikamatsu</surname><given-names>K.</given-names></name><name><surname>Sakakura</surname><given-names>K.</given-names></name><name><surname>Hatsushika</surname><given-names>K.</given-names></name><name><surname>Takahashi</surname><given-names>G.</given-names></name><name><surname>Masuyama</surname><given-names>K.</given-names></name></person-group> (<year>2009</year>). <article-title>Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck.</article-title>
<source><italic>Oral. Oncol.</italic></source>
<volume>45</volume>
<fpage>633</fpage>&#x02013;<lpage>639</lpage>.<pub-id pub-id-type="pmid">19027347</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>S.</given-names></name><name><surname>Zhan</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>B.</given-names></name><name><surname>Liu</surname><given-names>B.</given-names></name></person-group> (<year>2019</year>). <article-title>Identification of Biomarkers for Controlling Cancer Stem Cell Characteristics in Bladder Cancer by Network Analysis of Transcriptome Data Stemness Indices.</article-title>
<source><italic>Front. Oncol.</italic></source>
<volume>9</volume>:<issue>613</issue>. <pub-id pub-id-type="doi">10.3389/fonc.2019.00613</pub-id>
<?supplied-pmid 31334127?><pub-id pub-id-type="pmid">31334127</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>S. G.</given-names></name><name><surname>Shin</surname><given-names>H.</given-names></name><name><surname>Shin</surname><given-names>Y. K.</given-names></name><name><surname>Lee</surname><given-names>Y.</given-names></name><name><surname>Choi</surname><given-names>E. C.</given-names></name><name><surname>Park</surname><given-names>B. J.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>The novel cytokine p43 stimulates dermal fibroblast proliferation and wound repair.</article-title>
<source><italic>Am. J. Pathol.</italic></source>
<volume>166</volume>
<fpage>387</fpage>&#x02013;<lpage>398</lpage>. <pub-id pub-id-type="doi">10.1016/s0002-9440(10)62262-6</pub-id><pub-id pub-id-type="pmid">15681823</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>Y. M.</given-names></name><name><surname>Hwang</surname><given-names>S. J.</given-names></name><name><surname>Masuda</surname><given-names>K.</given-names></name><name><surname>Choi</surname><given-names>K. M.</given-names></name><name><surname>Jeong</surname><given-names>M. R.</given-names></name><name><surname>Nam</surname><given-names>D. H.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Heterogeneous nuclear ribonucleoprotein C1/C2 controls the metastatic potential of glioblastoma by regulating PDCD4.</article-title>
<source><italic>Mol. Cell Biol.</italic></source>
<volume>32</volume>
<fpage>4237</fpage>&#x02013;<lpage>4244</lpage>. <pub-id pub-id-type="doi">10.1128/mcb.00443-12</pub-id>
<?supplied-pmid 22907752?><pub-id pub-id-type="pmid">22907752</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pei</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name></person-group> (<year>2020</year>). <article-title>Identification of key genes controlling breast cancer stem cell characteristics via stemness indices analysis.</article-title>
<source><italic>J. Transl. Med.</italic></source>
<volume>18</volume>:<issue>74</issue>.</mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peitzsch</surname><given-names>C.</given-names></name><name><surname>Nathansen</surname><given-names>J.</given-names></name><name><surname>Schniewind</surname><given-names>S. I.</given-names></name><name><surname>Schwarz</surname><given-names>F.</given-names></name><name><surname>Dubrovska</surname><given-names>A.</given-names></name></person-group> (<year>2019</year>). <article-title>Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma: Identification, Characterization and Clinical Implications.</article-title>
<source><italic>Cancers</italic></source>
<volume>11</volume>(5):616. <pub-id pub-id-type="doi">10.3390/cancers11050616</pub-id>
<?supplied-pmid 31052565?><pub-id pub-id-type="pmid">31052565</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname><given-names>H. S.</given-names></name><name><surname>Kharbanda</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>R.</given-names></name><name><surname>Forrest</surname><given-names>W. F.</given-names></name><name><surname>Soriano</surname><given-names>R. H.</given-names></name><name><surname>Wu</surname><given-names>T. D.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.</article-title>
<source><italic>Cancer Cell</italic></source>
<volume>9</volume>
<fpage>157</fpage>&#x02013;<lpage>173</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccr.2006.02.019</pub-id>
<?supplied-pmid 16530701?><pub-id pub-id-type="pmid">16530701</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prince</surname><given-names>M. E.</given-names></name><name><surname>Sivanandan</surname><given-names>R.</given-names></name><name><surname>Kaczorowski</surname><given-names>A.</given-names></name><name><surname>Wolf</surname><given-names>G. T.</given-names></name><name><surname>Kaplan</surname><given-names>M. J.</given-names></name><name><surname>Dalerba</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma.</article-title>
<source><italic>Proc. Natl. Acad. Sci. U S A.</italic></source>
<volume>104</volume>
<fpage>973</fpage>&#x02013;<lpage>978</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0610117104</pub-id>
<?supplied-pmid 17210912?><pub-id pub-id-type="pmid">17210912</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>Z. Q.</given-names></name><name><surname>Li</surname><given-names>Q. G.</given-names></name><name><surname>Yi</surname><given-names>H.</given-names></name><name><surname>Lu</surname><given-names>S. S.</given-names></name><name><surname>Huang</surname><given-names>W.</given-names></name><name><surname>Rong</surname><given-names>Z. X.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Heterozygous p53-R280T Mutation Enhances the Oncogenicity of NPC Cells Through Activating PI3K-Akt Signaling Pathway.</article-title>
<source><italic>Front. Oncol.</italic></source>
<volume>10</volume>:<issue>104</issue>. <pub-id pub-id-type="doi">10.3389/fonc.2020.00104</pub-id>
<?supplied-pmid 32117754?><pub-id pub-id-type="pmid">32117754</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reya</surname><given-names>T.</given-names></name><name><surname>Morrison</surname><given-names>S. J.</given-names></name><name><surname>Clarke</surname><given-names>M. F.</given-names></name><name><surname>Weissman</surname><given-names>I. L.</given-names></name></person-group> (<year>2001</year>). <article-title>Stem cells, cancer, and cancer stem cells.</article-title>
<source><italic>Nature</italic></source>
<volume>414</volume>
<fpage>105</fpage>&#x02013;<lpage>111</lpage>.<pub-id pub-id-type="pmid">11689955</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schramek</surname><given-names>D.</given-names></name><name><surname>Kotsinas</surname><given-names>A.</given-names></name><name><surname>Meixner</surname><given-names>A.</given-names></name><name><surname>Wada</surname><given-names>T.</given-names></name><name><surname>Elling</surname><given-names>U.</given-names></name><name><surname>Pospisilik</surname><given-names>J. A.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>The stress kinase MKK7 couples oncogenic stress to p53 stability and tumor suppression.</article-title>
<source><italic>Nat. Genet</italic></source>
<volume>43</volume>
<fpage>212</fpage>&#x02013;<lpage>219</lpage>. <pub-id pub-id-type="doi">10.1038/ng.767</pub-id>
<?supplied-pmid 21317887?><pub-id pub-id-type="pmid">21317887</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>A. L.</given-names></name><name><surname>Owen</surname><given-names>J. H.</given-names></name><name><surname>Hauff</surname><given-names>S. J.</given-names></name><name><surname>Park</surname><given-names>J. J.</given-names></name><name><surname>Papagerakis</surname><given-names>S.</given-names></name><name><surname>Bradford</surname><given-names>C. R.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Head and neck cancer stem cells: the effect of HPV&#x02013;an in vitro and mouse study.</article-title>
<source><italic>Otolaryngol. Head Neck. Surg.</italic></source>
<volume>149</volume>
<fpage>252</fpage>&#x02013;<lpage>260</lpage>. <pub-id pub-id-type="doi">10.1177/0194599813486599</pub-id>
<?supplied-pmid 23585151?><pub-id pub-id-type="pmid">23585151</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>H.</given-names></name><name><surname>Guan</surname><given-names>D.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name></person-group> (<year>2018</year>). <article-title>Identifying osteosarcoma metastasis associated genes by weighted gene co-expression network analysis (WGCNA).</article-title>
<source><italic>Medicine</italic></source>
<volume>97</volume>:<issue>e10781</issue>. <pub-id pub-id-type="doi">10.1097/md.0000000000010781</pub-id>
<?supplied-pmid 29901575?><pub-id pub-id-type="pmid">29901575</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Tian</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>G.</given-names></name><name><surname>Qin</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Six-gene signature for predicting survival in patients with head and neck squamous cell carcinoma.</article-title>
<source><italic>Aging</italic></source>
<volume>12</volume>
<fpage>767</fpage>&#x02013;<lpage>783</lpage>. <pub-id pub-id-type="doi">10.18632/aging.102655</pub-id>
<?supplied-pmid 31927533?><pub-id pub-id-type="pmid">31927533</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Tan</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Zou</surname><given-names>Q.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response.</article-title>
<source><italic>Embo J.</italic></source>
<volume>37</volume>:<issue>e99017</issue>.</mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wyss</surname><given-names>A.</given-names></name><name><surname>Hashibe</surname><given-names>M.</given-names></name><name><surname>Chuang</surname><given-names>S. C.</given-names></name><name><surname>Lee</surname><given-names>Y. C.</given-names></name><name><surname>Zhang</surname><given-names>Z. F.</given-names></name><name><surname>Yu</surname><given-names>G. P.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Cigarette, cigar, and pipe smoking and the risk of head and neck cancers: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium.</article-title>
<source><italic>Am. J. Epidemiol.</italic></source>
<volume>178</volume>
<fpage>679</fpage>&#x02013;<lpage>690</lpage>.<pub-id pub-id-type="pmid">23817919</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>W.</given-names></name><name><surname>Bai</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Chi</surname><given-names>B.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name></person-group> (<year>2017</year>). <article-title>ANP32A modulates cell growth by regulating p38 and Akt activity in colorectal cancer.</article-title>
<source><italic>Oncol. Rep.</italic></source>
<volume>38</volume>
<fpage>1605</fpage>&#x02013;<lpage>1612</lpage>. <pub-id pub-id-type="doi">10.3892/or.2017.5845</pub-id>
<?supplied-pmid 28731192?><pub-id pub-id-type="pmid">28731192</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Shi</surname><given-names>P.</given-names></name><name><surname>Zhao</surname><given-names>G.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Peng</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Targeting cancer stem cell pathways for cancer therapy.</article-title>
<source><italic>Sign. Transduct. Target Ther.</italic></source>
<volume>5</volume>:<issue>8</issue>.</mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Kumar</surname><given-names>B.</given-names></name><name><surname>Piao</surname><given-names>L.</given-names></name><name><surname>Xie</surname><given-names>X.</given-names></name><name><surname>Schmitt</surname><given-names>A.</given-names></name><name><surname>Arradaza</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Elevated intrinsic cancer stem cell population in human papillomavirus-associated head and neck squamous cell carcinoma.</article-title>
<source><italic>Cancer</italic></source>
<volume>120</volume>
<fpage>992</fpage>&#x02013;<lpage>1001</lpage>. <pub-id pub-id-type="doi">10.1002/cncr.28538</pub-id>
<?supplied-pmid 24382806?><pub-id pub-id-type="pmid">24382806</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Tseng</surname><given-names>J. T.</given-names></name><name><surname>Lien</surname><given-names>I. C.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name><name><surname>Wu</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name></person-group> (<year>2020</year>). <article-title>mRNAsi Index: Machine Learning in Mining Lung Adenocarcinoma Stem Cell Biomarkers.</article-title>
<source><italic>Genes</italic></source>
<volume>11</volume>:<issue>257</issue>. <pub-id pub-id-type="doi">10.3390/genes11030257</pub-id>
<?supplied-pmid 32121037?><pub-id pub-id-type="pmid">32121037</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>G. B.</given-names></name><name><surname>Tang</surname><given-names>Y. C.</given-names></name><name><surname>Sinha</surname><given-names>R. A.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Yap</surname><given-names>C. S.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Genetic and bioinformatic analyses of the expression and function of PI3K regulatory subunit PIK3R3 in an Asian patient gastric cancer library.</article-title>
<source><italic>BMC Med. Genom.</italic></source>
<volume>5</volume>:<issue>34</issue>. <pub-id pub-id-type="doi">10.1186/1755-8794-5-34</pub-id>
<?supplied-pmid 22876838?><pub-id pub-id-type="pmid">22876838</pub-id></mixed-citation></ref></ref-list></back></article>